Showing results (171-180 of 264) with videos related to

Sort By:
Pageof 27
The International Journal of Neuropsychopharmacology|January 6, 2010
Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASBGonzalo Laje, Dara M Cannon, Andrew S Allen, et al.
Brain, Behavior, and Immunity|June 25, 2017
Altered populations of natural killer cells, cytotoxic T lymphocytes, and regulatory T cells in major depressive disorder: Association with sleep disturbanceHideo Suzuki, Jonathan Savitz, T Kent Teague, et al.
Archives of General Psychiatry|September 6, 2006
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controlsAlexander Neumeister, Xian-Zhang Hu, David A Luckenbaugh, et al.
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research|December 28, 2017
Quantification of 5-HT<sub>1A</sub> and 5-HT<sub>2A</sub> receptor Binding in Depressed Suicide Attempters and Non-AttemptersJ John Mann, Allison V Metts, R Todd Ogden, et al.
Fertility and Sterility|June 5, 2007
Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography studyEydie L Moses-Kolko, Katherine L Wisner, Julie C Price, et al.
Psychoneuroendocrinology|December 9, 2014
Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorderJonathan Savitz, Robert Dantzer, Brent E Wurfel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 12, 2023
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 studyNaim Zaki, Li Nancy Chen, Rosanne Lane, et al.
Biological Psychiatry|June 23, 2009
The effects of tryptophan depletion on neural responses to emotional words in remitted depressionJonathan P Roiser, Jamey Levy, Stephen J Fromm, et al.
The American Journal of Psychiatry|April 17, 2018
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled StudyCarla M Canuso, Jaskaran B Singh, Maggie Fedgchin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 31, 2014
Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorderJonathan Savitz, Wayne C Drevets, Chelsey M Smith, et al.
Pageof 27